Phone: +44 141 899 0081

Archive

Home / Tag: regulatory affairs

Kinesys Consulting secures its first PIM designation from UK MHRA under the EAMS – Early Access to Medicines Scheme

Kinesys Consulting has secured its first PIM designation, for a novel oncology supportive care product, on behalf of a US partner. The product, designated as a Promising Innovative Medicine (PIM) by the Medicines and Healthcare Products Regulatory Agency (MHRA), is being developed for